Antimicrobial Activity of Copper Alloys Against Invasive Multidrug-Resistant Nosocomial Pathogens

Size: px
Start display at page:

Download "Antimicrobial Activity of Copper Alloys Against Invasive Multidrug-Resistant Nosocomial Pathogens"

Transcription

1 Curr Microbiol (215) 71: DOI 1.17/s Antimicrobial Activity of Copper Alloys Against Invasive Multidrug-Resistant Nosocomial Pathogens Ozgen Koseoglu Eser 1 Alper Ergin 2 Gulsen Hascelik 1 Received: 8 December 214 / Accepted: 18 April 215 / Published online: 5 June 215 Springer Science+Business Media New York 215 Abstract The emergence and spread of antibiotic resistance demanded novel approaches for the prevention of nosocomial infections, and metallic copper surfaces have been suggested as an alternative for the control of multidrug-resistant (MDR) bacteria in surfaces in the hospital environment. This study aimed to evaluate the antimicrobial activity of copper material for invasive MDR nosocomial pathogens isolated over time, in comparison to stainless steel. Clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) (n:4), OXA-23 and OXA- 58 positive, MDR Acinetobacter baumannii (n:6) and Pseudomonas aeruginosa (n:4) were evaluated. The antimicrobial activity of coupons containing 99 % copper and a brass alloy containing 63 % copper was assessed against stainless steel. All the materials demonstrated statistically significant differences within each other for the logarithmic reduction of microorganisms. Among the three materials, the highest reduction of microorganisms was seen in 99 % copper and the least in stainless steel. The result was statistically significant especially for, 2, and 4 h (P =.5). 99 % copper showed a bactericidal effect at less than 1 h for MRSA and at 2 h for P. aeruginosa. 63 % copper showed a bactericidal effect at 24 h for P. aeruginosa strains only. Stainless steel surfaces exhibited a bacteriostatic effect after 6 h for P. aeruginosa strains only. 99 % copper reduced the number of bacteria used significantly, produced a bactericidal effect and was more effective than & Ozgen Koseoglu Eser ozgen.eser@hacettepe.edu.tr 1 2 Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey School of Health Services, Hacettepe University, Ankara, Turkey 63 % copper. The use of metallic copper material could aid in reducing the concentration of bacteria, especially for invasive nosocomial pathogens on hard surfaces in the hospital environment. Introduction Multidrug-resistant (MDR) and extremely drug-resistant (XDR) pathogens are a serious and emerging threat to patients in healthcare settings and have a significant impact on mortality, cost and length of hospital stay [6, 11, 19]. Most frequent MDR pathogens are described as ESCAPE pathogens by taking the first initials of Enterococcus, Staphylococcus aureus, Clostridium difficile, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae [19]. Overuse of antibiotics due to increasing levels of antimicrobial resistance especially against these pathogens continues to reduce the number of the few effective antimicrobial agents. The hospital environment is an important source for contributing to cross-infection. Effective removal of nosocomial pathogens from the hospital environment can be reduced by disinfectants and detergents. Stainless steel is widely used in the healthcare environment because it is corrosion resistant to most cleaning materials and always appears clean although it has no antimicrobial activity. The progressive erosion of therapeutic actions has been forced to receive renewed attention against biocidal surfaces in reducing nosocomial infections. The use of copper alloy biocidal surfaces could help to prevent the spread of microorganisms in healthcare settings [24]. Copper is an essential element at low concentrations as a cofactor for living organisms. The utilization of copper alloys at high concentrations proved to exhibit toxic effects by contact

2 292 O. Koseoglu Eser et al.: Antimicrobial Activity of Copper Alloys Against Invasive killing most microorganisms [5, 18, 22]. Copper and many copper alloys have already been registered at the U.S. Environmental Protection Agency (EPA) in 28 as the first solid antimicrobial material. A number of hospital trials in which rooms have been fitted with copper alloy door handles, bathroom fixtures, and tabletops have been conducted or are ongoing [12]. The aim of the present study was to evaluate the antimicrobial activity of copper surfaces for invasive MDR nosocomial pathogens isolated over time in comparison to stainless steel. Materials and Methods Bacterial Strains Invasive clinical isolates of multidrug-resistant (MDR), OXA-23 (n:5) and OXA-58 (n:1) positive A. baumannii (n:6), P. aeruginosa (n:4) and methicillin-resistant Staphylococcus aureus (MRSA)(n:4) isolated from blood cultures were evaluated. Species identification was performed using the BD Phoenix system (Sparks, MD, USA). The Cefoxitin disk screen test was used for the confirmation of MRSA strains as suggested by CLSI [3]. Antibiotic susceptibility of the isolates was determined by the microdilution method in accordance with guidelines of CLSI [3]. All the tested A. baumannii and P. aeruginosa isolates were resistant to all groups of antibiotics (beta-lactam and beta-lactamase combinations including third generation cephalosporins and carbapenems, as well as fluoroquinolones) except colistin. The MRSA isolates were also resistant to clindamycin, erythromycin, trimethoprim-sulphamethoxazole, and ciprofloxacin. Polymerase chain reaction with specific primers was used for confirmation of the presence of bla OXA-23 and bla OXA-58 genes. Standard strains of three microorganisms S. aureus ATCC 25923, A. baumannii DSM 37, and P. aeruginosa ATCC were also used in all experiments. Copper and Stainless Coupons The antimicrobial activity of copper, metal coupons (ACR Chemicals, Turkey) (1 cm 2 ) containing 99 % Cu (Cu99) and a brass alloy containing 63 % Cu (Cu63Zn37) was assessed. Coupons were cleaned before use by the modified method of Noyce et al. [16]. The coupons were degreased and cleaned by vortexing in 1 ml of acetone containing 3 glass beads of 2 mm diameter. After cleaning, the coupons were sterilized with absolute ethanol and flamed in a Bunsen burner. Sterilized coupons were placed in sterile glass tubes until use. Stainless steel coupons were sterilized using the same method and used as control in all experiments. Bacterial Viability Tests Organisms grown on sheep blood agar were adjusted to.5 McFarland standard. Ten microlitres of this suspension ( cfu) was inoculated on each of the three coupons, which were then incubated at room temperature (2 25 C) for, 2, 4, 6, and 24 h. Time was considered the time the aliquot dried. At each time interval coupons were aseptically removed and placed into 5 ml aliquots of sterile phosphate buffered saline (PBS) containing 2 glass beads and vortexed 6 s. The aliquots were serially diluted and plated onto sheep blood agar plates in duplicate and incubated at 37 C for 18 h for the determination of surviving bacteria. The lower limit of detection was.69 log 1 cfu/cm 2. The survival over time on each of the surfaces was expressed as mean log 1 cfu/cm 2 of all isolates of the same species at each time point. Bacteriostatic activity was defined as a C2 to\3 log 1 reduction and bactericidal activity as a C 3 log 1 reduction in the cfu from the inoculum at time on that surface. Statistical Analysis Effects of coupon, bacteria and coupon-bacteria relations in accordance with bacterial log reduction were compared using two-way variance analysis. Mean viable counts (log 1 cfu/cm 2 ) after incubation at each time interval with each coupon were compared statistically using one-way analysis of variance. The Bonferroni test was used to determine the reason of significant variance analysis differences within the materials. All differences with P \.5 were considered statistically significant. All statistical analyses were determined using the IBM SPSS 2. Statistics program. Results All the materials (Cu99, Cu63, and stainless steel) demonstrated statistically significant differences within each other for logarithmic reduction of microorganisms (P \.1). All three materials showed statistical significance for the log reduction of microorganisms (P \.1). Among the three materials, the highest reduction of microorganisms was seen in Cu99 (-3.17 ±.118) and the least in stainless steel (-.526 ±.118). At times, 2, and 4 h, only Cu99 showed a significant difference for log bacterial reduction (P \.5) and no

3 O. Koseoglu Eser et al.: Antimicrobial Activity of Copper Alloys Against Invasive 293 significance for Cu63 and stainless steel among all microorganisms. At 6 and 24 h, there was no significant difference between the three materials for all microorganisms (P [.5). The inactivation of microorganisms on different surfaces against time is shown in Fig. 1. Bactericidal and bacteriostatic effects of Cu63, Cu99, and SS against microorganisms in each time interval, meaning the difference between mean starting inoculum and mean viable cell count (D log 1 cfu/cm 2 ) of microorganisms, are shown in Table 1. Cu99 showed a bactericidal effect of less than 1 h for MRSA, 2 h for P. aeruginosa and exhibited a closer bactericidal range effect against A. baumannii starting from time zero (Table 1). Cu63 showed a bactericidal effect at 24 h for only P. aeruginosa among the isolates studied. Stainless steel surfaces exhibited a bacteriostatic effect after 6 h for P. aeruginosa strains only (Table 1). Discussion Environmental surfaces in the hospital setting act as an important reservoir for pathogenic microorganisms that cause nosocomial infections. Nosocomial pathogens may survive on hard surfaces, viable for long periods of time depending on the type of microorganism and environmental conditions [1, 1]. Preventive interventions to reduce the levels of microbial contamination decrease nosocomial infections in hospital settings [27]. There is an urgent need for new approaches in the field of infection control and the antimicrobial activity of copper could provide such an approach for the current measures to prevent dissemination of nosocomial MDR strains in hospitals. In an attempt to mimic in vivo conditions, various laboratory-based studies have used numerous methods to show the efficacy of copper against pathogenic organisms Fig. 1 Inactivation of six A. baumannii (a), four P. aeruginosa (b), and four MRSA (c) isolates on copper alloy (Cu63 %), copper (Cu99 %) and SS. Results are shown as mean number of viable colonies against time intervals (a) (b) (c)

4 294 O. Koseoglu Eser et al.: Antimicrobial Activity of Copper Alloys Against Invasive Table 1 Bactericidal and bacteriostatic effects of Cu63, Cu99, and SS against microorganisms in each time interval Surface material Acinetobacter baumannii Cu Cu a a a a a SS Pseudomonas aeruginosa Cu a a a b Cu a b b b b SS a a Staphylococcus aureus Cu Cu b -3.2 b -3.2 b -3.2 b -3.2 b SS a Bacteriostatic b Bactericidal effect [13, 22]. There are mainly two wet and dry inoculation techniques used in studies and it has been shown that temperature, humidity, the copper content of alloys and the dry technique increase the efficacy of copper contact killing [8]. We have decided to use the droplet technique (dry method) in our study, since this technique has been proved to show more reproducible results than the other method. According to our results, 99 % copper exhibited the highest reduction of microorganisms and the significance was particularly apparent at, 2, and 4 h time intervals. The bactericidal effect of 99 % copper was shorter than the other studies that have evaluated multidrug-resistant bacteria [2, 7, 22, 23]. Two separate studies, Warnes and Keevil [26] and Santo et al. [2], recently published that killing of bacteria on a dry copper surface can be as short as 2 1 min. This situation is in agreement with our data but the tested microorganisms (enterococci and nonpathogenic Gram positive bacteria) were different from the strains used in our study. Our results show that organisms such as ESBL producing MDR A. baumannii, methicillinresistant S. aureus and MDR P. aeruginosa were killed relatively quickly on the 99 % copper surface. All A. baumannii, P. aeruginosa and MRSA isolates were nearly killed within 6 min, in other words the antimicrobial resistance patterns and resistance genes of the isolates did not appear to have an effect on the antimicrobial activity of 99 % copper. Many of the previous studies have examined pure copper as well as copper-based alloys and in all of these studies the pure copper was shown to be the most effective contact material [7, 9, 15]. The problem is the question of the copper content of the environmental surfaces since 99 % copper is a flexible metal and therefore likely to wear faster than a copper alloy such as brass or zinc which are hard and more durable metals, so in some cases copper alloys can be used like copper zinc or brass [14, 17, 25]. Copper is the only hard surface metal that has received approval by the EPA and this approval has now been given to nearly 3 different copper alloys. This is an important step for the protection of public health and hospital environment issues [4]. According to our results, 63 % copper alloy had compatible results for P. aeruginosa. This alloy had a bacteriostatic effect starting from the 2 h period and had reached a bactericidal effect in the 24 h period against our P. aeruginosa isolates. There was no statistically significant difference between the three materials for all microorganisms in 6 and 24 h but 63 % copper and stainless steel surfaces exhibited a and log1 cfu/cm 2 change in initial inoculum of P. aeruginosa at 24 h. The results have shown the non-surviving characteristics of this microorganism on dry surfaces. This data might be an alternative in case of consideration of better strength for contact surfaces of hospital environments. The results of this study expanded the results of preliminary observations concerning the bactericidal efficacy of 99 % copper and validated the previous reports [22]. Our results have two main differences from previous studies. The main difference of the study concerned the duration of the killing time interval of 99 % Cu. According to our results, it was almost zero time for such problematic MDR nosocomial bacterial strains. The second important result concerned the bactericidal effect of 63 %Cu in P. aeruginosa isolates. This data might be important with regard to the usage of a more durable and effective material in hospital settings. The strong efficacy of copper alloys against several types of invasive MDR pathogens indicates that this material should be subjected to evaluation in hospital settings, especially in intensive care units. The bactericidal efficacy of copper as part of a contact surface has been extensively studied but the clinical impact of this efficacy is unclear. Limited hospital trials have demonstrated that significant reductions in nosocomial infections were observed when copper alloys were used in hospital settings [21]. Further to the laboratory and clinical research results, there is now a great interest in producing objectives that will be used by manufacturers in high nosocomial areas like ICUs and medical wards [4]. The current study has some limitations. We only demonstrated the in vitro efficacy of copper alloys and stainless steel against the pathogens used. We could not evaluate the efficacy of copper alloys under indoor conditions in hospital settings but the isolates used were all nosocomial invasive strains and had the characteristics of multidrug-resistant pathogens, which can provide evidence for the serious problems in ICUs and other hospital areas.

5 O. Koseoglu Eser et al.: Antimicrobial Activity of Copper Alloys Against Invasive 295 Other nosocomial pathogens such as vancomycin-resistant enterococci or Clostridium difficile could be included in the study but these pathogens are still not a frequent cause of hospital-acquired infections in our country. As a result, 99 % copper reduced the number of bacteria used significantly and produced a bactericidal effect and was more effective than 63 % copper alloy and stainless steel. The data suggests that use of copper as a surface material could aid in eliminating the environmental reservoir of important invasive nosocomial pathogens and may reduce the opportunity for the cross-transfer of these superbugs in the hospital environment. However, it is still worth saying that the decision for the implementation of copper contact in hospital settings should be given after further clinical trials. Acknowledgments This study was presented in the 114th General Meeting of the American Society for Microbiology, May 17 2, 214, Boston, Massachusetts, USA. We would like to thank Selçuk Korkmaz (Hacettepe University, Department of Biostatistics) for interpreting the statistical analysis of the data and Tülay Özçelik for technical assistance. References 1. Borkow G, Monk A (212) Fighting nosocomial infections with biocidal non-intrusive hard and soft surfaces. World J Infect Dis 2: Cervantes HI, Alvarez JA, Munoz JM, Arreguin V, Mosqueda JL, Macias AE (213) Antimicrobial activity of copper against organisms in aqueous solution: a case for copper-based water pipelines in hospitals? Am J Infect Control 41:e115 e Clinical and Laboratory Standards Institute (CLSI) (213) Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement CLSI document M1- S23, Wayne, PA, USA 4. Efstathiou PA (211) The role of antimicrobial copper surfaces in reducing healthcare-associated infections. Eur Infect Dis 5: Espirito Santo C, Law EW, Elowsky CG, Quaranta D, Domaille DW, Chang CJ et al (211) Bacterial killing by dry metallic copper surfaces. Appl Environ Microbiol 77: Giske CG, Monnet DL, Cars O, Carmeli Y (28) Clinical and economic impact of common multidrug resistant gram negative bacilli. Antimicrob Agents Chemother 52: Gould SWJ, Fielder MD, Kelly AF, Morgan M, Kenny J, Naughton DP (29) The antimicrobial properties of copper surfaces against a range of important nosocomial pathogens. Ann Microbiol 59: Grass G, Rensing C, Solioz M (211) Metallic copper as an antimicrobial surface. Appl Environ Microbiol 77: Huang HI, Shih HY, Lee CM, Yang TC, Lay JJ, Lin YE (28) In vitro efficacy of copper and silver ions in eradicating Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Acinetobacter baumannii: implications for on-site disinfection for hospital infection control. Water Res 42: Kramer A, Schwebke I, Kampf G (26) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6: Maragakis LL (21) Recognition and prevention of multidrugresistant gram negative bacteria in the intensive care unit. Crit Care Med 38: Mathews S, Hans M, Mücklich F, Solioz M (213) Contact killing of bacteria on copper is suppressed if bacterial-metal contact is prevented and is induced on iron by copper ions. Appl Environ Microbiol 79: Mehtar S, Wild I, Todorov SD (28) The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in vitro study. J Hosp Infect 68: Michels HT, Noyce JO, Keevil CW (29) Effects of temperature and humidity on the efficacy of methicillin-resistant Staphylococcus aureus challenged antimicrobial materials containing silver and copper. Lett Appl Microbiol 49: Monk AB, Kanmukhla V, Trinder K, Borkow G (214) Potent bactericidal efficacy of copper oxide impregnated non-porous solid surfaces. BMC Microbiol 14: Noyce JO, Michels H, Keevil CW (26) Potential use of copper surfaces to reduce survival of epidemic meticillin-resistant Staphylococcus aureus in the healthcare environment. J Hosp Infect 63: Noyce JO, Michels HT, Keevil CW (26) Use of copper cast alloys to control Escherichia coli 157 cross-contamination during food processing. Appl Environ Microbiol 72: O Gorman J, Humphreys H (212) Application of copper to prevent and control infection. Where are we now? J Hosp Infect 81: Peterson LR (29) Bad bugs, no drugs: no ESCAPE revisited. Clin Infect Dis 49: Santo CE, Morais PV, Grass G (21) Isolation and characterization of bacteria resistant to metallic copper surfaces. Appl Environ Microbiol 76: Salgado CD, Sepkowitz KA, John JF (213) Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol 34: Souli M, Galani I, Plachouras D, Panagea T, Armaganidis A, Petrikkos G et al (213) Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates. J Antimicrob Chemother 68: Varghese S, ElFakhri SO, Sheel DW, Sheel P, Bolton FJE, Foster HA (213) Antimicrobial activity of novel nanostructured Cu- SiO 2 coatings prepared by chemical vapour deposition against hospital related pathogens. AMB Express 3: Warnes SL, Highmore CJ, Keevil CW (212) Horizontal transfer of antibiotic resistance genes on abiotic touch surfaces: Implications for public health. mbio 3:e Warnes SL, Green SM, Michels HT, Keevil CW (21) Biocidal efficacy of copper alloys against pathogenic enterococci involves degradation of genomic and plasmid DNAs. Appl Environ Microbiol 76: Warnes SL, Keevil CW (211) Mechanism of copper surface toxicity in vancomycin-resistant enterococci following wet or dry surface contact. Appl Environ Microbiol 77: Weber DJ, Anderson D, Rutala WA (213) The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis 26:

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS Adrienn Hanczvikkel 1, András Vígh 2, Ákos Tóth 3,4 1 Óbuda University, Budapest,

More information

Antimicrobial Copper Touch Surfaces: A new tool for Infection Control and Prevention

Antimicrobial Copper Touch Surfaces: A new tool for Infection Control and Prevention Antimicrobial Copper Touch Surfaces: A new tool for Infection Control and Prevention Wilton Moran Project Engineer Copper Development Association The Science Behind the Technology Digital Summit Infection

More information

New and Innovative Applications for Metals COPPER. Tony Lea International Copper Association

New and Innovative Applications for Metals COPPER. Tony Lea International Copper Association New and Innovative Applications for Metals COPPER Tony Lea International Copper Association SUPERBUGS 2 HOSPITAL ACQUIRED INFECTIONS Infections acquired during hospital stays kill more people than breast

More information

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3 Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University Tae-yoon Choi ABSTRACT BACKGROUND: The use of disinfectants

More information

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011 Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System Guidelines for Laboratory Verification of Performance of the FilmArray BCID System Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes quality standards for all laboratory

More information

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How

More information

Is biocide resistance already a clinical problem?

Is biocide resistance already a clinical problem? Is biocide resistance already a clinical problem? Stephan Harbarth, MD MS University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland Important points Biocide resistance exists Antibiotic

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Multi-drug resistant microorganisms

Multi-drug resistant microorganisms Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the

More information

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical

More information

Problem: Hospital Acquired Infections

Problem: Hospital Acquired Infections Antimicrobial Copper: new market opportunities International Copper Association Codelco Problem: Hospital Acquired Infections 2 Hospital acquired infections (HAIs): Worldwide 7,000,000 infections per year

More information

MICRO-ORGANISMS by COMPANY PROFILE

MICRO-ORGANISMS by COMPANY PROFILE MICRO-ORGANISMS by COMPANY PROFILE 2017 1 SAPROPHYTES AND PATHOGENES SAPROPHYTES Not dangerous PATHOGENES Inducing diseases Have to be eradicated WHERE ARE THERE? EVERYWHERE COMPANY PROFILE 2017 3 MICROORGANISMS

More information

Appropriate antimicrobial therapy in HAP: What does this mean?

Appropriate antimicrobial therapy in HAP: What does this mean? Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 4: Antibiotic Resistance Author M.P. Stevens, MD, MPH S. Mehtar, MD R.P. Wenzel, MD, MSc Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues

More information

Summary of the latest data on antibiotic resistance in the European Union

Summary of the latest data on antibiotic resistance in the European Union Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network

More information

Human health impacts of antibiotic use in animal agriculture

Human health impacts of antibiotic use in animal agriculture Human health impacts of antibiotic use in animal agriculture Beliefs, opinions, and evidence Peter Davies BVSc, PhD College of Veterinary Medicine, University of Minnesota, USA Terminology Antibiotic Compound

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

A Study on Bacterial Flora on the Finger printing Surface of the Biometric Devices at a Tertiary Care Hospital

A Study on Bacterial Flora on the Finger printing Surface of the Biometric Devices at a Tertiary Care Hospital International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 9 (2016) pp. 441-446 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.509.047

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007

More information

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified

More information

The Hospital Environment as a Source of Resistant Gram Negatives

The Hospital Environment as a Source of Resistant Gram Negatives Avondale College ResearchOnline@Avondale Nursing and Health Conference Papers Faculty of Nursing and Health 2013 The Hospital Environment as a Source of Resistant Gram Negatives Brett G. Mitchell Avondale

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD

More information

Nosocomial Infections: What Are the Unmet Needs

Nosocomial Infections: What Are the Unmet Needs Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

Fighting MDR Pathogens in the ICU

Fighting MDR Pathogens in the ICU Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine Mike Apley Kansas State University Changes in Food Animal Antibiotic Use How the uses of antibiotics in

More information

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus TEST REPORT TEST TYPE: Liquid Suspension Time Kill Study -Quantitative Test Based On ASTM 2315 TEST METHOD of Colloidal Silver Product at Contact time points: 30 sec, 1 min, 2 min, 5 min, 10 min, 15 min

More information

Mechanism of antibiotic resistance

Mechanism of antibiotic resistance Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance

More information

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the

More information

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections Robin Isaacs Chief Medical Officer, Entasis Therapeutics Dr. Isaacs is a full-time employee of Entasis Therapeutics.

More information

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase

More information

Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients

Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients TABLE 1. Origin and carbapenem resistance characteristics of the 64 Acinetobacter baumannii stock D-750 Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Mike Apley Kansas State University

Mike Apley Kansas State University Mike Apley Kansas State University 2003 - Daptomycin cyclic lipopeptides 2000 - Linezolid - oxazolidinones 1985 Imipenem - carbapenems 1978 - Norfloxacin - fluoroquinolones 1970 Cephalexin - cephalosporins

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of

More information

BACTERIOLOGICALL STUDY OF MICROORGANISMS ON MOBILES AND STETHOSCOPES USED BY HEALTH CARE WORKERS IN EMERGENCY AND ICU S

BACTERIOLOGICALL STUDY OF MICROORGANISMS ON MOBILES AND STETHOSCOPES USED BY HEALTH CARE WORKERS IN EMERGENCY AND ICU S Research Article Harika A,, 2013; Volume 2(3): 290-297 ISSN: 2277-8713 BACTERIOLOGICALL STUDY OF MICROORGANISMS ON MOBILES AND STETHOSCOPES USED BY HEALTH CARE WORKERS IN EMERGENCY AND ICU S HARIKAA A,

More information

Risk of organism acquisition from prior room occupants: A systematic review and meta analysis

Risk of organism acquisition from prior room occupants: A systematic review and meta analysis Risk of organism acquisition from prior room occupants: A systematic review and meta analysis A/Professor Brett Mitchell 1-2 Dr Stephanie Dancer 3 Dr Malcolm Anderson 1 Emily Dehn 1 1 Avondale College;

More information

(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE

(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE (DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE John Ferguson (Hunter New England, NSW) on behalf of MRGN Task Force Acknowledgement

More information

Antimicrobial Cycling. Donald E Low University of Toronto

Antimicrobial Cycling. Donald E Low University of Toronto Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and

More information

CAVICIDE1. Technical Bulletin

CAVICIDE1. Technical Bulletin CAVICIDE1 Technical Bulletin CaviCide1 is a multi-purpose disinfectant intended for use in cleaning, decontaminating and disinfecting hard non-porous, inanimate surfaces and non-critical instruments in

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut This presentation Definitions needed to discuss antimicrobial resistance

More information

Horizontal vs Vertical Infection Control Strategies

Horizontal vs Vertical Infection Control Strategies GUIDE TO INFECTION CONTROL IN THE HOSPITAL Chapter 14 Horizontal vs Vertical Infection Control Strategies Author Salma Abbas, MBBS Michael Stevens, MD, MPH Chapter Editor Shaheen Mehtar, MBBS. FRC Path,

More information

Mono- versus Bitherapy for Management of HAP/VAP in the ICU

Mono- versus Bitherapy for Management of HAP/VAP in the ICU Mono- versus Bitherapy for Management of HAP/VAP in the ICU Jean Chastre, www.reamedpitie.com Conflicts of interest: Consulting or Lecture fees: Nektar-Bayer, Pfizer, Brahms, Sanofi- Aventis, Janssen-Cilag,

More information

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Antimicrobial stewardship: Quick, don t just do something! Stand there! Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger

More information

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding

More information

Quality assurance of antimicrobial susceptibility testing

Quality assurance of antimicrobial susceptibility testing Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly

More information

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007 GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXVII NUMBER 6 July 2012 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine B. Dowell SM, MLS (ASCP); Sarah K. Parker, MD; James K. Todd, MD Each year the Children s Hospital Colorado

More information

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier

More information

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms Nimalie D. Stone, MD,MS Division of Healthcare Quality Promotion National

More information

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length

More information

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation

More information

Antimicrobial Resistance

Antimicrobial Resistance Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length

More information

Antimicrobial Resistance Acquisition of Foreign DNA

Antimicrobial Resistance Acquisition of Foreign DNA Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple

More information

Original Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e.

Original Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e. Iranian Journal of Pharmaceutical Research (22), (2): 559-563 Received: January 2 Accepted: June 2 Copyright 22 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services

More information

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY MDROs and Hand Hygiene Guidelines HH Apr14 The Science of Hand Hygiene in Healthcare Settings

More information

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium www.ivis.org Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium May 17-20, 2015 Fort Collins, CO, USA Reprinted in the IVIS website with the permission

More information

Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):

Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4): Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S

More information

SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data

SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data 408 SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data Physical Properties Active Ingredient: Chloroxylenol (PCMX) 0.3% Appearance: Clear, Amber Solution Fragrance: Floral Form: Liquid

More information

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University

More information

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org

More information

WHY IS THIS IMPORTANT?

WHY IS THIS IMPORTANT? CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change

More information

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat

More information

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug

More information

Multi-Drug Resistant Organisms (MDRO)

Multi-Drug Resistant Organisms (MDRO) Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause

More information

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria? Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany Should we screen for multiresistant gramnegative Bacteria? CONCLUSIONS: A program of universal surveillance, contact precautions,

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

New Drugs for Bad Bugs- Statewide Antibiogram

New Drugs for Bad Bugs- Statewide Antibiogram New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

A solution for current veterinary challenges

A solution for current veterinary challenges A solution for current veterinary challenges 2 www.jakmarketing.co.uk Introduction The current disease challenge in veterinary practices is increasingly coming from pathogens that are resistant to both

More information

DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION. Cara Wilder Ph.D. Technical Writer March 13 th 2014

DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION. Cara Wilder Ph.D. Technical Writer March 13 th 2014 DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION Cara Wilder Ph.D. Technical Writer March 13 th 2014 ATCC Founded in 1925, ATCC is a non-profit organization with headquarters in Manassas,

More information

Other Enterobacteriaceae

Other Enterobacteriaceae GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 50: Other Enterobacteriaceae Author Kalisvar Marimuthu, MD Chapter Editor Michelle Doll, MD, MPH Topic Outline Topic outline - Key Issues Known

More information

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and

More information

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED 2018 Printed copies must not be considered the definitive version DOCUMENT CONTROL POLICY NO. IC-122 Policy Group Infection Control

More information

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital, Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at

More information

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program Introducing BIOGUARD No-leaching. >99.999% No-resistance. No-toxicity. Just cost-efficient, broad-spectrum, rapid effectiveness you can rely on. Best-in-class dressings for your infection control program

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.

More information

Stratégie et action européennes

Stratégie et action européennes Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial

More information

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser

More information

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Int.J.Curr.Microbiol.App.Sci (2018) 7(8): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378

More information

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data 508 SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data Physical Properties Active Ingredient: Ethyl Alcohol 62% (70% v/v) Appearance: Clear, Colorless Solution Fragrance: Floral Form:

More information

Antimicrobial Resistance Strains

Antimicrobial Resistance Strains Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

Susceptibility Pattern of Some Clinical Bacterial Isolates to Selected Antibiotics and Disinfectants

Susceptibility Pattern of Some Clinical Bacterial Isolates to Selected Antibiotics and Disinfectants Polish Journal of Microbiology 2008, Vol. 57, No 3, 199 204 ORIGINAL PAPER Susceptibility Pattern of Some Clinical Bacterial Isolates to Selected Antibiotics and Disinfectants JUDE N. OGBULIE, IFECHUKWU

More information

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant

More information

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City Journal of Antimicrobial Chemotherapy Advance Access published July 31, 2010 J Antimicrob Chemother doi:10.1093/jac/dkq278 Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information

Testimony of the Natural Resources Defense Council on Senate Bill 785

Testimony of the Natural Resources Defense Council on Senate Bill 785 Testimony of the Natural Resources Defense Council on Senate Bill 785 Senate Committee on Healthcare March 16, 2017 Position: Support with -1 amendments I thank you for the opportunity to address the senate

More information

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013 Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases

More information